CAXTON CORP - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q4 2021$15,158,000
-9.8%
2,522,0830.0%12.39%
-9.0%
Q3 2021$16,797,000
+7.8%
2,522,083
+7.6%
13.61%
+27.5%
Q2 2021$15,583,000
-20.4%
2,343,333
+10.8%
10.68%
-16.1%
Q1 2021$19,583,000
-48.5%
2,114,8400.0%12.72%
-46.4%
Q4 2020$38,046,000
+45.3%
2,114,840
+14.6%
23.72%
-3.9%
Q3 2020$26,183,000
+227.6%
1,845,164
+15.7%
24.69%
+192.6%
Q2 2020$7,992,0001,595,1648.44%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$15,158,00012.39%
Octagon Capital Advisors LP 982,753$5,906,0001.15%
Altium Capital Management LP 337,000$2,025,0000.56%
ACT CAPITAL MANAGEMENT, LLC 102,500$616,0000.44%
Eventide Asset Management 1,670,399$10,039,0000.13%
Artal Group S.A. 750,000$4,508,0000.12%
Aquatic Capital Management LLC 8,000$48,0000.09%
ELKHORN PARTNERS LIMITED PARTNERSHIP 17,300$104,0000.06%
Anson Funds Management LP 69,381$417,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 170,447$1,024,0000.02%
View complete list of CARDIFF ONCOLOGY INC shareholders